Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Jones

Drugs

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Drugs|January 1, 1988
In vitro evaluations of aminopenicillin/beta-lactamase inhibitor combinationsR N Jones
Drugs|January 1, 1981
Cefoperazone: spectrum of antibacterial activity and disc diffusion testingC Thornsberry, R N Jones
Drugs|January 1, 1996
Emerging resistance to antimicrobial agents in gram-positive bacteria. Enterococci, staphylococci and nonpneumococcal streptococciM G Cormican, R N Jones
Drugs|March 16, 2000
Oxazolidinones: a reviewD I Diekema, R N Jones
Drugs|January 1, 1988
Cefotaxime single-dose surgical prophylaxis in a prepaid group practice. Comparisons with other cephalosporins and ticarcillin/clavulanic acidR N Jones, J M Slepack, W V Wojeski
Drugs|January 1, 1993
The epidemiology of bacterial resistance to quinolonesJ F Acar, T F O'Brien, F W Goldstein, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Drugs|January 1, 1988
In vitro evaluations of aminopenicillin/beta-lactamase inhibitor combinationsR N Jones
Drugs|January 1, 1981
Cefoperazone: spectrum of antibacterial activity and disc diffusion testingC Thornsberry, R N Jones
Drugs|January 1, 1996
Emerging resistance to antimicrobial agents in gram-positive bacteria. Enterococci, staphylococci and nonpneumococcal streptococciM G Cormican, R N Jones
Drugs|March 16, 2000
Oxazolidinones: a reviewD I Diekema, R N Jones
Drugs|January 1, 1988
Cefotaxime single-dose surgical prophylaxis in a prepaid group practice. Comparisons with other cephalosporins and ticarcillin/clavulanic acidR N Jones, J M Slepack, W V Wojeski
Drugs|January 1, 1993
The epidemiology of bacterial resistance to quinolonesJ F Acar, T F O'Brien, F W Goldstein, et al.
Pageof 1